Skip to main content
Skip to section navigation
Skip to footer
Top
INVESTORS
Home
Investors
Contact
About
Welcome
Mission
Partnering
Patents
A.I. Platform
Our Technology
RADR
®
Collaborations
Pipeline
Overview
LP100
|
LP184
|
LP284
|
LP300
| ADC Program
Clinical Trials
Compassionate Use
Publications
Posters
TEAM
Leadership
Board of Directors
Advisors
Lantern Careers
MEDIA
News
Press
Social Media
Newsletter
Videos
Webinars
Contact
Investors
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Media Coverage
Email Alerts
Company Info
Overview
Management Team
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity
Filing Type:
View All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
Date
Form
Description
PDF
XBRL
Pages
06/08/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
06/08/20
CERT
View Filing
1
06/08/20
8-A12B
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
3
06/08/20
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-5.1
EX-10.3
13
06/02/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
05/29/20
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
2
05/22/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
3
05/22/20
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
2
05/19/20
FWP
Filing under Securities Act Rules 163/433 of free writing prospectuses
38
05/19/20
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-1.1
EX-3.1(IV)
EX-3.1(V)
EX-4.1(IV)
EX-10.3
EX-10.4
EX-10.15
EX-10.16
EX-23.1
317
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
Page
18
Page
19
Next Page
arrow_forward
Email Alerts
Company Profile
Contacts
RSS News Feed
Join our Mailing List to get the latest Lantern news, sent right to your inbox
We're sorry
, but this form has spam protection that requires JavaScript to be enabled to work correctly. If you'd like to contact us via this form, please
enable scripts in your browser
and reload the page.
First Name
Last Name
Email Address
Sign me up for:
All Press Releases
Subscribe
This site is protected by hCaptcha and its
Privacy Policy
and
Terms of Service
apply.
Never spam. Unsubscribe anytime.
Tweets by LanternPharma